Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2019 - 2026)
Amphastar Pharmaceuticals (AMPH) posted Amortization of Deferred Charges of $500000.0 for Q2 2026, down 34.3% on a QoQ basis from $761000.0 in Q1 2026, and little changed year-over-year from $500000.0 in Q2 2025.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Amphastar Pharmaceuticals has reported Amortization of Deferred Charges for 8 years, with the latest figure at $500000.0 in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $500000.0 in Q2 2026; TTM through Jun 2026 was $2.6 million, a 5.67% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, down 44.38% from the prior year.
- Amortization of Deferred Charges was $500000.0 for Q2 2026 at Amphastar Pharmaceuticals, down from $761000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $5.2 million in Q3 2023, with the low at $30000.0 in Q4 2022.
- Average Amortization of Deferred Charges over 5 years is $1.1 million, with a median of $500000.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges jumped 9610.0% in 2023, then tumbled 90.45% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $30000.0 in 2022, then surged by 9610.0% to $2.9 million in 2023, then tumbled by 75.15% to $724000.0 in 2024, then gained by 19.61% to $866000.0 in 2025, then plunged by 42.26% to $500000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $500000.0 (Q2 2026), $761000.0 (Q1 2026), and $866000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 761,000.00 |
| Dec 31, 2025 | 866,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 762,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 5.24 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | -2.25 Mn |
| Sep 30, 2021 | 782,000.00 |
| Jun 30, 2021 | 826,000.00 |